Mission

Our primary goal is to provide comprehensive, up-to-date, research-based information on systemic scleroderma diagnosis and treatments. We believe that patients who are educated about their disease can work more effectively with their team of physicians to make the best possible individual care decisions.

We are also focused on research to test a novel disease pathogenesis model that we originally proposed in 1993. If this disease model turns out to be correct, it is likely to lead to new treatments for systemic scleroderma that are more effective and much safer than current, largely ineffective, treatments that are currently being used.